INDIA

COVAXIN Phase 3 Clinical Trials Data Submitted to DCGI by Bharat Biotech, Say Govt Sources

Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend, Say Govt sources.

Published: Jun 22, 2021 10:02 AM IST

Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend: Govt sources.

Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend: Govt sources pic.twitter.com/ggXSxQCaAc
— ANI (@ANI) June 21, 2021

(The above story first appeared on LatestLY on Jun 21, 2021 09:58 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).

COVAXIN Phase 3 Clinical Trials Data Submitted to DCGI by Bharat Biotech, Say Govt Sources

Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend, Say Govt sources.

Related Topics

You May Also Like

Bird Flu Mutation Could Trigger Pandemic Worse Than COVID-19, Warns French Expert; Says Global Risk Remains Low For Now

Mississippi: 'Aggressive' Monkey on Loose After Tulane University Truck Accident on I-59 in Jasper County Shot and Killed by Homeowner Who Feared Her Children's Safety

Fact Check: Did Escaped Monkeys in Mississippi Carry Hepatitis C, Herpes and COVID? Tulane University Refutes Claim

Mississippi: 'Aggressive' Monkey on Loose in Heidelberg After Tulane University Truck Carrying Lab Monkeys Potentially Infected With Hepatitis C, Herpes and COVID Crashes on I-59 in Jasper County (Video)